1. Home
  2. VNDA vs DENN Comparison

VNDA vs DENN Comparison

Compare VNDA & DENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • DENN
  • Stock Information
  • Founded
  • VNDA 2002
  • DENN 1953
  • Country
  • VNDA United States
  • DENN United States
  • Employees
  • VNDA N/A
  • DENN 3800
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • DENN Restaurants
  • Sector
  • VNDA Health Care
  • DENN Consumer Discretionary
  • Exchange
  • VNDA Nasdaq
  • DENN Nasdaq
  • Market Cap
  • VNDA 249.4M
  • DENN 317.7M
  • IPO Year
  • VNDA 2006
  • DENN 1989
  • Fundamental
  • Price
  • VNDA $4.41
  • DENN $6.16
  • Analyst Decision
  • VNDA Strong Buy
  • DENN Buy
  • Analyst Count
  • VNDA 3
  • DENN 6
  • Target Price
  • VNDA $14.00
  • DENN $5.45
  • AVG Volume (30 Days)
  • VNDA 682.0K
  • DENN 2.6M
  • Earning Date
  • VNDA 10-29-2025
  • DENN 11-03-2025
  • Dividend Yield
  • VNDA N/A
  • DENN N/A
  • EPS Growth
  • VNDA N/A
  • DENN N/A
  • EPS
  • VNDA N/A
  • DENN 0.20
  • Revenue
  • VNDA $212,074,000.00
  • DENN $457,212,000.00
  • Revenue This Year
  • VNDA $14.32
  • DENN $7.62
  • Revenue Next Year
  • VNDA $37.05
  • DENN $1.92
  • P/E Ratio
  • VNDA N/A
  • DENN $31.41
  • Revenue Growth
  • VNDA 11.12
  • DENN 0.93
  • 52 Week Low
  • VNDA $3.81
  • DENN $2.85
  • 52 Week High
  • VNDA $5.70
  • DENN $7.73
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 34.91
  • DENN 67.52
  • Support Level
  • VNDA $4.32
  • DENN $3.86
  • Resistance Level
  • VNDA $4.51
  • DENN $6.19
  • Average True Range (ATR)
  • VNDA 0.23
  • DENN 0.23
  • MACD
  • VNDA -0.13
  • DENN 0.16
  • Stochastic Oscillator
  • VNDA 9.44
  • DENN 98.50

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About DENN Denny's Corporation

Denny's Corp is America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees. Geographically operates in USA states as well as globally like Canada, Mexico, Guatemala, Indonesia, United Kingdom, New Zealand and others. Maximum revenue is from USA and Canada.

Share on Social Networks: